These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 174500)

  • 1. Estrogen receptor and natural course of breast cancer.
    Singhakowinta A; Potter HG; Buroker TR; Samal B; Brooks SC; Vaitkevicius VK
    Ann Surg; 1976 Jan; 183(1):84-8. PubMed ID: 174500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the pathologic and prognostic correlates of estrogen receptors in primary breast cancer.
    Skinner JR; Wanebo HJ; Betsill WL; Wilhelm MC; Drake CR; Macleod RM
    Ann Surg; 1982 Dec; 196(6):636-41. PubMed ID: 7149814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The surgical implications of estrophile protein estimations in carcinoma of the breast.
    Walt AJ; Singhakowinta A; Brooks SC; Cortez A
    Surgery; 1976 Oct; 80(4):506-12. PubMed ID: 184556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of relapse and survival in breast cancer patients by pS2 protein status.
    Foekens JA; Rio MC; Seguin P; van Putten WL; Fauque J; Nap M; Klijn JG; Chambon P
    Cancer Res; 1990 Jul; 50(13):3832-7. PubMed ID: 2354435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells.
    Ogba N; Manning NG; Bliesner BS; Ambler SK; Haughian JM; Pinto MP; Jedlicka P; Joensuu K; Heikkilä P; Horwitz KB
    Breast Cancer Res; 2014 Dec; 16(6):489. PubMed ID: 25475897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of relapse and metastatic spread in HER2-overexpressing breast cancer according to estrogen receptor status.
    Park YH; Lee S; Cho EY; Choi YL; Lee JE; Nam SJ; Yang JH; Ahn JS; Im YH
    Cancer Chemother Pharmacol; 2010 Aug; 66(3):507-16. PubMed ID: 19956951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptors and breast cancer: prognostic and therapeutic implications.
    Gapinski PV; Donegan WL
    Surgery; 1980 Sep; 88(3):386-93. PubMed ID: 7414516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prediction of hormonal dependency of mammary cancer.
    Block GE; Jensen EV; Polley TZ
    Ann Surg; 1975 Sep; 182(3):342-52. PubMed ID: 169754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro clonogenic growth and metastatic potential of human operable breast cancer.
    Nomura Y; Tashiro H; Hisamatsu K
    Cancer Res; 1989 Oct; 49(19):5288-93. PubMed ID: 2766296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor heterogeneity and the relationship between estrogen receptor and the tritiated thymidine labeling index in human breast cancer.
    Straus MJ; Moran R; Muller RE; Wotiz HH
    Oncology; 1982; 39(4):197-200. PubMed ID: 7088469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The correlation between estrogen receptor status, axillary-node metastases and disease-free interval after surgery in primary breast cancer.
    Caldarola L; Calderini P; Volterrani P; Di Carlo F; Gaglia P
    Ital J Surg Sci; 1983; 13(3):179-85. PubMed ID: 6643007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemically determined estrogen receptor phenotype remains stable in recurrent and metastatic breast cancer.
    Gomez-Fernandez C; Daneshbod Y; Nassiri M; Milikowski C; Alvarez C; Nadji M
    Am J Clin Pathol; 2008 Dec; 130(6):879-82. PubMed ID: 19019763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate binding protein and the estrogen receptor in breast cancer.
    Rochman H; Selhub J; Karrison T
    Cancer Detect Prev; 1985; 8(1-2):71-5. PubMed ID: 4064054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor status in breast cancer.
    Wright CJ
    Can J Surg; 1980 Jul; 23(4):316-7. PubMed ID: 7417890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective analysis of metastatic behaviour of breast cancer subtypes.
    Savci-Heijink CD; Halfwerk H; Hooijer GK; Horlings HM; Wesseling J; van de Vijver MJ
    Breast Cancer Res Treat; 2015 Apr; 150(3):547-57. PubMed ID: 25820592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor profile of patients with breast cancer metastatic to bone marrow.
    Budd GT
    J Surg Oncol; 1983 Nov; 24(3):167-9. PubMed ID: 6632904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical outcome of receptor expression discordance between primary and metastatic breast cancer].
    Mu YX; Zhang P; Ma F; Yuan P; Wang JY; Xu BH; Li Q
    Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):506-511. PubMed ID: 30060358
    [No Abstract]   [Full Text] [Related]  

  • 18. Survival analysis of breast cancer subtypes in patients with spinal metastases.
    Wang M; Jensen AB; Morgen SS; Wu CS; Sun M; Li H; Dahl B; Bünger CE
    Spine (Phila Pa 1976); 2014 Sep; 39(19):1620-7. PubMed ID: 24979144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor determination and long term survival of patients with carcinoma of the breast.
    Crowe JP; Gordon NH; Hubay CA; Shenk RR; Zollinger RM; Brumberg DJ; McGuire WL; Shuck JM
    Surg Gynecol Obstet; 1991 Oct; 173(4):273-8. PubMed ID: 1925896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor conversion in metastatic breast cancer: a prognosticator of survival.
    Meng X; Song S; Jiang ZF; Sun B; Wang T; Zhang Sh; Wu Sh
    Oncotarget; 2016 Nov; 7(44):71887-71903. PubMed ID: 27655689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.